Study of drug release and tablet characteristics of silicone adhesive matrix tablets

被引:23
|
作者
Tolia, Gaurav [1 ]
Li, S. Kevin [1 ]
机构
[1] Univ Cincinnati, Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
基金
美国国家科学基金会;
关键词
Controlled release; Silicone adhesive; Ethyl cellulose; Polymers; Tablet strength; Binary mixture; HYDROXYPROPYL METHYLCELLULOSE; DOSAGE FORMS; COMPRESSION; POLYMERS; ETHYLCELLULOSE; PARACETAMOL; PREDICTION; DISPERSION; SUCCINATE; CELLULOSE;
D O I
10.1016/j.ejpb.2012.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Matrix tablets of a model drug acetaminophen (APAP) were prepared using a highly compressible low glass transition temperature (T-g) polymer silicone pressure sensitive adhesive (PSA) at various binary mixtures of silicone PSA/APAP ratios. Matrix tablets of a rigid high T-g matrix forming polymer ethyl cellulose (EC) were the reference for comparison. Drug release study was carried out using USP Apparatus 1 (basket), and the relationship between the release kinetic parameters of APAP and polymer/APAP ratio was determined to estimate the excipient percolation threshold. The critical points attributed to both silicone PSA and EC tablet percolation thresholds were found to be between 2.5% and 5% w/w. For silicone PSA tablets, satisfactory mechanical properties were obtained above the polymer percolation threshold; no cracking or chipping of the tablet was observed above this threshold. Rigid EC APAP tablets showed low tensile strength and high friability. These results suggest that silicone PSA could eliminate issues related to drug compressibility in the formulation of directly compressed oral controlled release tablets of poorly compressible drug powder such as APAP. No routinely used excipients such as binders, granulating agents, glidants, or lubricants were required for making an acceptable tablet matrix of APAP using silicone PSA. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [21] CHITOSAN MATRIX TABLETS - THE INFLUENCE OF EXCIPIENTS ON DRUG-RELEASE
    KRISTMUNDSDOTTIR, T
    INGVARSDOTTIR, K
    SAEMUNDSDOTTIR, G
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (13) : 1591 - 1598
  • [22] Drug Release from Oral Matrix Tablets Containing Hypromelose
    Dvorackova, Katerina
    CHEMICKE LISTY, 2009, 103 (01): : 66 - 72
  • [23] Evaluation of sodium alginate as drug release modifier in matrix tablets
    Liew, CV
    Chan, LW
    Ching, AL
    Heng, PWS
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 309 (1-2) : 25 - 37
  • [24] Drug release from matrix tablets and minitablets containing glycerides
    Ratsimbazafy, V
    Bourret, E
    Brossard, C
    PHARMAZEUTISCHE INDUSTRIE, 1996, 58 (05): : 442 - 446
  • [25] Stereoselective drug release from ketoprofen and ricobendazole matrix tablets
    Alvarez, C
    Torrado, JJ
    Cadórniga, R
    CHIRALITY, 1999, 11 (08) : 611 - 615
  • [26] EFFECT OF PRESSING POWER, DRUG PARTICLE-SIZE, DRUG FORM AND TEST MEDIUM ON ACTIVE PRINCIPLE RELEASE FROM SILICONE MATRIX TABLETS
    MOLDENHAUER, H
    KALA, H
    ERBE, S
    PHARMAZIE, 1975, 30 (12): : 783 - 787
  • [27] Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine
    Nahla S. Barakat
    Ibrahim M. Elbagory
    Alanood S. Almurshedi
    AAPS PharmSciTech, 2008, 9 : 931 - 938
  • [28] Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine
    Barakat, Nahla S.
    Elbagory, Ibrahim M.
    Almurshedi, Alanood S.
    AAPS PHARMSCITECH, 2008, 9 (03) : 931 - 938
  • [29] Evaluation of granulation, excipient characteristics, and drug solubility in the preparation of hydrophilic controlled-release matrix tablets
    Cabelka, TD
    Sheskey, PJ
    23RD INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, 1996 PROCEEDINGS, 1996, : 805 - 806
  • [30] Modifying drug release and tablet properties of starch acetate tablets by dry powder agglomeration
    Maki, Riikka
    Suihko, Eero
    Rost, Susanne
    Heiskanen, Minna
    Murtomaa, Matti
    Lehto, Vesa-Pekka
    Ketolainen, Jarkko
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (02) : 438 - 447